Orion Healthcare scoops up Aspyra

Orion Healthcare Ventures has completed the transaction to acquire the assets of Aspyra for an undisclosed sum.

The Westlake Village, Calif.-based Aspyra said it will continue operations under its current name. “There were several private equity firms and larger companies that approached Aspyra during the past year but those offers were not in the best interest of all stakeholders,” Aspyra said.

Orion is an investment firm with a focus on health IT enterprises. Aspyra develops health IT services, delivering workflow technologies for imaging and laboratory marketplaces. Its applications include laboratory information systems, PACS and RIS.

In October 2009, Aspyra gave notice to the N.Y. Stock Exchange to voluntarily delist its common stock from the exchange and deregistered its common stock under the Securities Exchange Act of 1934.

“Aspyra was able to generate positive cash flow in 2010 despite challenging economic conditions,” said Orion’s Managing Director Shawn Chalmers, adding its intention to invest in Aspyra’s research and development unit.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup